ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

JANX Janux Therapeutics Inc

47.39
0.29 (0.62%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Janux Therapeutics Inc JANX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.29 0.62% 47.39 09:00:00
始値 安値 高値 終値 前日終値
47.08 46.51 48.23 47.39 47.10
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/0906:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0906:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0906:11EDGAR2Form 8-K - Current report
2024/3/0906:01BWJanux Therapeutics Reports Fourth Quarter and Full Year 2023..
2024/3/0107:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/3/0107:11EDGAR2Form 8-K - Current report
2024/2/2915:22BWJanux Therapeutics Announces Pricing of $296.5 Million..
2024/2/2911:55EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
2024/2/2907:15EDGAR2Form 8-K - Current report
2024/2/2811:50EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2807:23EDGAR2Form 8-K - Current report
2024/2/2807:00BWJanux Therapeutics Announces Proposed Public Offering of..
2024/2/2706:05BWJanux Announces Encouraging Safety and Efficacy Data in..
2024/2/2022:00BWJanux Therapeutics to Host Virtual Event Discussing Updated..
2024/2/1006:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0206:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/0823:00BWJanux Therapeutics Promotes Co-Founder Tommy DiRaimondo,..
2024/1/0406:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/11/0806:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0806:07EDGAR2Form 8-K - Current report
2023/11/0806:01BWJanux Therapeutics Reports Third Quarter 2023 Financial..
2023/9/0807:14EDGAR2Form 144 - Report of proposed sale of securities
2023/8/1505:33EDGAR2Form 144 - Report of proposed sale of securities
2023/8/0905:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0905:17EDGAR2Form 8-K - Current report
2023/8/0905:01BWJanux Therapeutics Reports Second Quarter 2023 Financial..
2023/7/1906:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/7/1905:16EDGAR2Form 8-K - Current report
2023/7/1721:45BWJanux Therapeutics Announces Pricing of $60 Million..
2023/7/1721:16EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
2023/7/1721:06EDGAR2Form 8-K - Current report
2023/7/1721:00BWJanux Therapeutics Announces Positive Interim Clinical Data..
2023/6/0605:35BWJanux Therapeutics Appoints Zachariah McIver, D.O., Ph.D.,..
2023/5/1005:01BWJanux Therapeutics Reports First Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock